FMP

FMP

Enter

GLAND.NS - Gland Pharma Limited

Financial Summary of Gland Pharma Limited(GLAND.NS), Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused ge

photo-url-https://financialmodelingprep.com/image-stock/GLAND.NS.png

Gland Pharma Limited

GLAND.NS

NSE

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.

1756.7 INR

-25.2001 (-1.43%)

About

ceo

Mr. Srinivas Sadu

sector

Healthcare

industry

Drug Manufacturers - General

website

https://www.glandpharma.com

exchange

NSE

Description

Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analg...

CIK

N/A

ISIN

INE068V01023

CUSIP

N/A

Address

Plot No. 11 & 84, TSIIC Phase:...

Phone

91 84 5569 9999

Country

IN

Employee

4,585

IPO Date

Nov 20, 2020

Summary

CIK

-

Exchange

NSE

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

-

ISIN

INE068V01023

Country

IN

Price

1.76k

Beta

0.36

Volume Avg.

503.88k

Market Cap

289.35B

Shares

-

52-Week

861.0-2194.0

DCF

1.23k

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

44.02

P/B

-

Website

https://www.glandpharma.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest GLAND.NS News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep